✦ LIBER ✦

Glutamate Receptor Binding Sites in MPTP-Treated Mice

✍ Scribed by U. Wüllner; E. Brouillet; O. Isacson; A.B. Young; J.B. Penney

Book ID: 115605999
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 320 KB
Volume: 121
Category: Article
ISSN: 0014-4886
DOI: 10.1006/exnr.1993.1098

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alteration of neurotensin receptors in M

Alteration of neurotensin receptors in MPTP-treated mice

✍ Hiroaki Tanji; Tsutomu Araki; Kazuo Fujihara; Haruo Nagasawa; Yasuto Itoyama 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Dopamine receptors and sensorimotor beha

Dopamine receptors and sensorimotor behavior in MPTP-treated mice

✍ Fredric B. Weihmuller; Maria Hadjiconstantinou; John P. Bruno 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 879 KB

Selective metabotropic receptor agonists

Selective metabotropic receptor agonists distinguish non-ionotropic glutamate binding sites

✍ Claudia M Testa; Zane R Hollingsworth; Haruhiko Shinozaki; John B Penney Jr.; An 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Neuroprotective effect of riluzole in MP

Neuroprotective effect of riluzole in MPTP-treated mice

✍ Tsutomu Araki; Toshihiko Kumagai; Katsuyuki Tanaka; Mitsunobu Matsubara; Hiroyuk 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Modafinil prevents the MPTP-induced incr

Modafinil prevents the MPTP-induced increase in GABAA receptor binding in the internal globus pallidus of MPTP-treated common marmosets

✍ B.-Y. Zeng; L.A. Smith; R.K.B. Pearce; B. Tel; L. Chancharme; G. Moachon; P. Jen 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Amantadine increases striatal dopamine t

Amantadine increases striatal dopamine turnover in MPTP-treated mice

✍ Patricia Rojas; Marina Altagracia; Jaime Kravzov; Camilo Rios 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB

## Abstract Amantadine is used in the symptomatic treatment of Parkinson's disease to improve the akinesia and rigidity associated with this neurodegenerative disorder. Amantadine acts on the synthesis and release of dopamine (DA). In order to further characterize its mechanism of action, the drug